Advertisement
Advertisement

MCRB

MCRB logo

Seres Therapeutics, Inc.

7.08
USD
Sponsored
+0.24
+3.43%
Jun 26, 16:00 UTC -4
Closed
exchange

After-Market

7.04

-0.04
-0.56%

Seres Therapeutics, Inc. Profile

About

Seres Therapeutics, Inc. offers microbiome therapeutics platform. It is focused on developing Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. Seres Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.

Info & Links

CEO

Richard N. Kender

Headquarters

101 CAMBRIDGEPARK DRIVE
CAMBRIDGE, MA 02140, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.serestherapeutics.com

Auditor

PricewaterhouseCoopers LLP

Share holders

11

Employees

66

Seres Therapeutics, Inc. Statistics

Valuation Measures

Market Capitalization2

68.17M

Enterprise Value

38.34M

Enterprise Value/EBITDA(ttm)

-0.46

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.78

Price to Cash(ytd)

8.02

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-290.95%

Return on Equity(ttm)

-111.10%

Return on Invested Capital(ttm)

-11.40%

Return on Assets(ttm)

-32.28%

Income Statement

Revenue(ttm)

1.15M

Revenue Per Share(ttm)

0.12

Gross Profit(ttm)

1.15M

EBITDA(ttm)3

-83.80M

Net Income Available to Common(ttm)

-46.90M

Diluted EPS(ttm)

0.66

Share Statistics

Beta (5Y Monthly)

0.26

52-Week Change

-25.55%

S&P 500 52-Week Change

19.13%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

9.68M

Dividend Yield

0.00%

Float4

9.13M

% Held by Insiders

4.70%

% Held by Institutions

59.34%

Balance Sheet

Total Cash(mrq)

29.83M

Total Cash Per Share(mrq)

3.08

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.56%

Quick Ratio(mrq)

2.56%

Book Value Per Share(mrq)

4.63

Cash Flow

Operating Cash Flow Per Share(ytd)

0.13

Free Cash Flow(ytd)

1.07M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement